INVO Fertility, Inc.
$1.00
The Read: 8% decline on product launch updates, driven by mixed financial transparency, liquidity concerns, and unmet market expectations, as seen in its July 1 rollout where initial gains gave way to a 11.
IVF
Hover to view data
No Data